Clinical Trial

Clinical Efficacy of Prophylactic Intravenous Neostigmine and Atropine in Preventing Post-Dural Puncture Headache Among Parturient Undergoing Spinal Anesthesia for Cesarean Section: A Double-blind Randomized Placebo-controlled Trial

Unknown Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated July 16, 2024 (before its estimated January 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
Post dural puncture headache is a distressing issue, many measures tried to treat symptoms but few delt with prevention.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06493838
Lead Sponsor Minia University
Conditions Acute Pain
Enrollment 180 participants
Start Date 2024-07-15
Primary Completion 2025-01-15 (estimated)
Study Completion 2025-01-16 (estimated)
Updated on ClinicalTrials.gov 2024-07-16